Friedman Lance

13D and 13G Filings

13D/G filings
13G on 2 securities
CIK
0001470622
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 2 securities · passive
Aspire Biopharma Holdings, Inc. 13G/A
ASBP · 738920305
7.9% 8/6/2026
Event 8/4/2026
Aspire Biopharma Holdings, Inc. 13G/A
ASBP · 738920107
4.5% 5/19/2025
Event 5/6/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.